Galectin Therapeutics (GALT) Cash from Financing Activities (2010 - 2026)
Galectin Therapeutics' Cash from Financing Activities came in at $1.6 million for Q2 2026, down 87.7% from $12.94 million a year earlier but up 521.4% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Galectin Therapeutics reported Cash from Financing Activities of $15.39 million, down 35.3% year-over-year; for FY2025, it came in at $26.48 million, down 15.2% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of 151.5% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $31.23 million in FY2024 (-22.0%), $40.03 million in FY2023 (+300.3%), $10 million in FY2022 (-72.8%) and $36.81 million in FY2021.
- The five-year range for quarterly Cash from Financing Activities is $257,000 (Q1 2026) to $12.94 million (Q2 2025).
- Year-over-year, Cash from Financing Activities increased in 1 of the last five quarters, with an average decline of 48.4%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2025 (growth of 24.7%), and the weakest in Q4 2024 (a decline of 91.5%).
- Business Quant data shows GALT's Cash from Financing Activities at $257,000 (Q1 2026), $12.24 million (Q4 2025) and $1.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Galectin Therapeutics | 257.29 Mn | 257.29 Mn | - | 1.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 257,000.00 |
| Dec 31, 2025 | 12.24 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 12.94 Mn |
| Dec 31, 2024 | 851,000.00 |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.38 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.03 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 16.82 Mn |
| Jun 30, 2020 | 44,000.00 |
| Mar 31, 2020 | 219,000.00 |
| Dec 31, 2019 | 902,000.00 |
API Access
Galectin Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();